GREGORY SKETAS: Open Payments
NPI 1710340088 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 34 payments from 12 companies in 2025. Trend: 2023 $753 · 2024 $762 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $155 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| PFIZER INC. | 2 | $33 |
| Novo Nordisk Inc | 2 | $33 |
| Lundbeck LLC | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $28 |
| Boston Scientific Corporation | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
Products named: VRAYLAR, REXULTI, AIRSUPRA, QULIPTA, UBRELVY, TRELEGY ELLIPTA, Veozah, WaveWriter Alpha Prime 16.
Industry payments across AR — which companies pay providers there.
